Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
| Cost of goods sold increase (decrease) | $ 12,567 | $ 8,503 | $ 21,325 | $ 16,675 |
| General and administrative | 9,417 | 10,550 | 19,373 | 20,611 |
| Decrease in research and development | (6,658) | (7,144) | (14,066) | (13,470) |
| Reduction to sales and marketing expense | (19,698) | (18,860) | (39,513) | (38,307) |
| Cash and cash equivalents balance outside of FDIC limit | $ 18,439 | $ 18,439 | ||
| Revision of Prior Period, Reclassification, Adjustment | ||||
| Cost of goods sold increase (decrease) | (3) | (6) | ||
| General and administrative | 922 | 1,984 | ||
| Decrease in research and development | 219 | 572 | ||
| Reduction to sales and marketing expense | 699 | 1,406 | ||
| Shipping and Handling | Revision of Prior Period, Change in Accounting Principle, Adjustment | ||||
| Cost of goods sold increase (decrease) | $ 1,278 | $ 2,743 | ||
| X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|